Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufacturing and supply chain strategies. After this period, tariffs will escalate significantly, impacting export economics. Several Indian firms already have US manufacturing operations for flexibility. The next two years will shape how India serves its largest overseas pharmaceutical market.

Raccontata datimesofindia.indiatimes.comeconomictimes.indiatimes.comhindustantimes.comfrance24.combenzinga.comnewsbytesapp.comthehindubusinessline.comtheprint.in